Utilizing central composite design (CCD) in the optimization of new HPLC-PDA method for the assay of daridorexant: Application to the analysis in bulk and tablet dosage forms

References

• Zainab, A., Anders, B., Hector, W.H., Mark, D., Shahub, H., Maurice, M. (2021). Sleep problems during COVID-19 pandemic and its’ association to psychological distress: A systematic review and meta-analysis. EClinical Medicine. 36(100916): 1-30.
   Google Scholar
• Hu, Z., Oh, S., Ha, T.W., Hong, J.T., Oh, K.W. (2018). Sleep-Aids Derived from Natural Products. Biomol Ther. 26(4): 343-349. doi: 10.4062/biomolther.2018.099
   PubMed Web of Science ®Google Scholar
• Markham, A. (2022). Daridorexant: First Approval. Drugs. 82(5): 601-607. doi: 10.1007/s40265-022-01699-y
   PubMed Web of Science ®Google Scholar
• Catherine, R., Giorgio, B., Michel, A., Martine, C. (2021). Nonclinical pharmacology of daridorexant: a new dual orexin receptor antagonist for the treatment of insomnia. Psycho-pharmacology (Berl). 238(10): 2693-2708. doi: 10.1007/s00213-021-05954-0
   PubMed Web of Science ®Google Scholar
• Nie, T., Blair, H.A. (2023). Daridorexant in Insomnia Disorder: A Profile of Its Use. CNS Drugs. 37(3): 267-274. doi: 10.1007/s40263-023-00987-9
   PubMed Web of Science ®Google Scholar
• Breidinger, S.A., Simpson, R.C., Mangin, E., Woolf, E.J. (2015). Determination of suvorexant in human plasma using 96-well liquid-liquid extraction and HPLC with tandem mass spectrometric detection. J Chromatogr B Analyt Technol Biomed Life Sci. 1(1002): 254-259. doi: 10.1016/j.jchromb.2015.07.056
   Google Scholar
• Sydney, S., Kelsie, B., Sarah, K. (2017). Identification of Suvorexant in Urine Using Liquid Chromatography-Quadrupole/Time-of-Flight Mass Spectrometry (LC-Q/TOF-MS). J. Anal. Toxicol. 41(3): 224-229.
   PubMed Web of Science ®Google Scholar
• Siddhartha, S., Santosh, T., Vijaya Ratna, J. (2018). Development and validation of HPLC method for the determination of Suvorexant in pharmaceutical dosage forms. Int J. Pharm. Drug. Anal. 6(3): 425-434.
   Google Scholar
• Skillman, B., Kerrigan, S. (2018). Quan-tification of suvorexant in blood using liquid chromatography-quadrupole/time of flight (LC-Q/TOF) mass spectrometry. J. Chromatogr. B. 1091: 87-95. doi: 10.1016/j.jchromb.2018.05.006
   PubMed Web of Science ®Google Scholar
• Rajana, N., Devi, D.R., Kumar Reddy, D.N., Babu, J.M., Basavaiah, K., Balakumaran, K. (2020). Characterization of Five Oxidative Degradation Impurities and One Process Impurity of Suvorexant Drug Substance by LC-MS/MS, HR-MS and 1D, 2D NMR: Validation of Suvorexant Drug Substance and Process Impurities by HPLC and UPLC. J. Chromatogr. Sci. 58(5): 433-444. doi: 10.1093/chromsci/bmaa003
   PubMed Web of Science ®Google Scholar
• Mohammed, H.A., Muzaffar, I., Ahmed, I.F., Tariq, M.A., Fatma, A.B., Sultan, A., Faiyaz, S., Prawez, A. (2023). Quantification of Suvorexant in Human Urine Using a Validated HPTLC Bioanalytical Method. ACS Omega. 8(42): 39928-39935. doi: 10.1021/acsomega.3c07123
   PubMed Web of Science ®Google Scholar
• Kamble, S.N., Munipalli, V.K., Talapadatur, H., Singh, R.M., Warde, S., Nayak, S., Vaidhun, B. (2022). Development and validation of novel HPLC method for analytical evaluation of Lemborexant in tablet dosage form. GSC Advanced Research and Reviews. 11(01): 132-143. doi: 10.30574/gscarr.2022.11.1.0086
   Google Scholar
• Muralikrishna, M., Nagavalli, S., Anjali, P., Balamani, D.P., Teja, D., Naik, P.K.J. (2020). Method development and validation of Lemborexant in bulk and its pharmaceutical dosage form by reverse phase-high performance liquid chromatography (RP-HPLC). World J. Pharm. Res. 14 (9): 1372-1380.
   Google Scholar
• Iqbal, M., Alshememry, A., Imam, F., Kalam, M.A., Akhtar, A., Ali, E.A. (2023). UPLC-MS/MS Based Identification and Quantification of a Novel Dual Orexin Receptor Antagonist in Plasma Samples by Validated SWGTOX Guide-lines. Toxics. 11(2): 109. doi: 10.3390/toxics11020109
   PubMed Web of Science ®Google Scholar
• United States Pharmacopeia, Chapter <1220> Analytical Procedure Life Cycle (1220). USP-NF 2022, Issue 1, 2022.
   Google Scholar
• USP Validation and Verification Expert Panel. Analytical Target Profile: Structure and Appli-cation throughout the Analytical Lifecycle. Pharmacop. Forum. 2016, 42, 5.
   Google Scholar
• Jaiprakash, N.S., Mrinmayee, D., Zahid Z., Devanand, B.S., Rohidas, A. (2017). Quality by design approach: Regulatory need. Arab. J. Chem. 10: S3412-S3425.
   Web of Science ®Google Scholar
• International Conference on Harmonization (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use, Q8 (R2): Harmonized tripartite guideline, Pharmaceutical Development: Geneva. 2009.
   Google Scholar
• International Conference on Harmonization (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use, Q9:(R1), Harmonized tripartite guideline, Quality Risk Management: Geneva. 2023.
   Google Scholar
• International Conference on Harmonization (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use, Harmonized tripartite guideline, Pharmaceutical Quality System: Geneva, 2008.
   Google Scholar
• International Conference on Harmonization (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use, Q11: Harmonized tripartite guideline, Development and Manufacture of Drug substances (chemical entities and biotechnological/ biological entities), Geneva, 2012.
   Google Scholar
• International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use, Q14 : Harmonized tripartite guideline, An Analytical Procedure Development, Draft Version: Geneva, 2022.
   Google Scholar
• Bezerra, M.A., Santelli, R.E., Oliveira, E.P., Villar, L.S., Escaleira, L.A. (2008). Response surface methodology (RSM) as a tool for opti-mization in analytical chemistry. Talanta. 76(5): 965-977. doi: 10.1016/j.talanta.2008.05.019
   PubMed Web of Science ®Google Scholar
• Candioti, L.V., De Zan, M.M., Camara, M.S., Goicoechea, H.C. (2014). Experimental design and multiple response optimization. Using the desirability function in analytical methods development. Talanta. 124: 123-138. doi: 10.1016/j.talanta.2014.01.034
   PubMed Web of Science ®Google Scholar
• Ramalingam, P., Bhadraya, K., Yirgamreddy, P.R. (2015). Analytical Quality by Design: A Tool for Regulatory Flexibility and Robust Analytics. Int. J. Anal. Chem. 2015: 1-9.
   Web of Science ®Google Scholar
• Susmitha, A., Rajitha, G., Gireesh Kumar, E. (2023). A comprehensive review on QbD driven analytical procedures developed for the analysis of various drugs. J. Liq. Chromatogr. Relat. Technol. 46(1-5): 12–36. doi: 10.1080/10826076.2023.2204238
   Web of Science ®Google Scholar
• Orlandini, S., Pinzauti, S., Furlanetto, S. (2013). Application of quality by design to the development of analytical separation methods. Anal. Bioanal. Chem. 405: 443-450. doi: 10.1007/s00216-012-6302-2
   PubMed Web of Science ®Google Scholar
• Yahya, B.A., Bawazir, A.S., Sangshetti, J.N., Shahajan, S.B., Sana, S.S. (2021). QbD-Based Development and Validation of an Efficient RPHPLC Method for Estimation of Abiraterone Acetate in Bulk, Tablet, and In-House-Developed Nano-Formulation. Anal. Chem. Lett. 11(1): 112-130. doi: 10.1080/22297928.2021.1888794
   Google Scholar
• Fukuda, I.M., Pinto, C.F.F., Moreira, C.D.S., Saviano, A.M., Felipe, R.L. (2018). Design of Experiments (DoE) applied to Pharmaceutical and Analytical Quality by Design (QbD). Braz. J. Pharm. Sci. 2018, 54: 1-16.
   Google Scholar
• Kelley, B., Cromwell, M., Jerkins, J. (2016). Integration of QbD risk assessment tools and overall risk management. Biologicals. 44 (5): 341-351. doi: 10.1016/j.biologicals.2016.06.001
   PubMed Web of Science ®Google Scholar
• Peraman, R., Bandi, J., Kondreddy, V.K., Kalva, B., Kothakota, S.G., Paritala, J., Nagappan, K., Yirgamreddy, P.R. (2021). Analytical quality by design approach versus conventional approach: Development of HPLC-DAD method for simultaneous determination of etizolam and propranolol hydrochloride. J. Liq. Chromatogr. Relat. Technol. 44(3-4): 197-209. doi: 10.1080/10826076.2021.1874982
   Web of Science ®Google Scholar
• Fouad, M.A., Elsabour, S.A., Elkady, E.F., Elshazly, H.M. (2022). Design of experiment (DOE), multiple response optimization and utilizing the desirability function in the simultaneous HPLC separation of five antihyper-tensive drugs. J. Iran. Chem. Soc. 19: 269-282. doi: 10.1007/s13738-021-02316-7
   Web of Science ®Google Scholar
• Jain, A., Beg, S., Saini, S., Teenu, S., Prakash, Om., Bhupinder, S. (2019). Application of chemometric approach for QbD-Enabled development and validation of an RP-HPLC method for estimation of methotrexate. J. Liq. Chromatogr. Relat. 43(1): 502-512. doi: 10.1080/10826076.2019.1626742
   Google Scholar
• Saini, S., Teenu, S., Asha, P., Ranjot, K., Tripathi, S.K., Katare, O.P., Bhupinder, S. (2020). QbD-steered development and validation of an RP-HPLC method for quantification of ferulic acid: Rational application of chemometric tools. J. Chromatogr. B. 1155: 122300. doi: 10.1016/j.jchromb.2020.122300
   PubMed Web of Science ®Google Scholar
• International Conference on Harmonization (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use, Q2 (R1): Harmonized tripartite guideline, validation of analytical procedures: text and methodology: Geneva, 2005.
   Google Scholar